News, archive: October 2019
Between January and September 2019, Russia manufactured 295 bln RUB worth of pharmaceutical drugs (manufacturers’ prices, VAT included), which is monetary terms (rubles) 22% higher than that in the same period in 2018. This is also the highest dynamics since 2016. The dynamics in physical terms (units) are +4.7%, or +4.2% if calculated in minimum dosage units (MDU). While these dynamics are far from those in 2016, these can still be considered high after the constant negative dynamics during 2017-2018.